Our Mission: "...To facilitate the translation of scientific Discovery into tomorrow’s medicines for the benefit of all cancer sufferers ..."

What We Do

ClinOx, and the internationally acknowledged network of clinical centres with whom we work, have the skills and experience to offer a wide range of services which can be tailored to meet the individual needs of its industry clients, whether pharmaceutical company or biotechnology firm. By working with its industry clients and the early phase clinical trials centres, ClinOx can provide the following services:

  • improved quality of the clinical trial protocol – ClinOx provides access to a "brains-trust" (cross-discipline therapy area expertise), thereby offering the opportunity to develop and refine the client’s clinical protocol. By tapping into this “brains-trust”, ClinOx can add value to its client’s product by improving the design and execution of sophisticated early phase clinical trials, including pharmacokinetic (PK), mechanistic pharmacodynamic (PD) and pharmacogenetic (PGx), and imaging (PET, MRI) endpoints. Many of the ClinOx investigators are already known to its industry clients because of their individual reputations for excellence in clinical validation of research hypotheses in early phase oncology trials;

  • productive relationships with centres of scientific and clinical excellence appropriate for current and future trials – ClinOx works with its industry clients to identify, broker and maintain sustained and productive relationships with clinical trial centres; and

  • rapid, efficient and cost-effective trial start up – ClinOx aims for rapid study site activation through:

    • rational approach to contractual negotiation and agreement – ClinOx can negotiate and manage standard contracts for each trial with selected centres. Contractual agreement is built upon the principle of consistent and transparent costs for laboratory and clinical services. Master agreements between ClinOx and industry clients enable efficient start-up of current and future trials;
       
    • managed approach to ethical and regulatory approval – in parallel with contractual negotiation and agreement, ClinOx can work with its industry clients to construct packages for timely ethical and regulatory approval; and
       
    • trial management and improved data quality – ClinOx is continually improving the quality and consistency of laboratory and clinical data by ensuring that milestones and endpoints are clearly agreed between industry clients and principal investigators; and by ensuring a highly trained workforce utilise industry standard tools. ClinOx works with its industry clients to conduct appropriate monitoring of the trials.